Asthma
MONDO:0004979A bronchial disease that is characterized by chronic inflammation and narrowing of the airways, which is caused by a combination of environmental and genetic factors resulting in recurring periods of wheezing (a whistling sound while breathing), chest tightness, shortness of breath, mucus production and coughing. The symptoms appear due to a variety of triggers such as allergens, irritants, respiratory infections, weather changes, exercise, stress, reflux disease, medications, foods and emotional anxiety.
Also known as: chronic obstructive asthma, chronic obstructive asthma with acute exacerbation, chronic obstructive asthma with status asthmaticus, exercise induced asthma, exercise-induced asthma
712 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Could a higher dose of an old asthma drug help kids breathe easier in an emergency?
Disease control CompletedThis study tests whether a high dose of montelukast (Singulair), given by mouth, can help children aged 4 to 12 who are in the hospital with a moderate or severe asthma attack. The goal is to find the best dose for a future larger study. Children receive either the high-dose mont…
Phase: PHASE2 • Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New asthma drug shows promise in cutting attacks
Disease control CompletedThis study tests an experimental drug called rocatinlimab in adults with moderate-to-severe asthma. The goal is to see if it can reduce the number of asthma attacks. Participants continue their usual asthma medications while receiving the drug or a placebo. The study involves abo…
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Could a Heart-Healthy diet tame uncontrolled asthma?
Disease control CompletedThis study investigates whether following the DASH diet—a heart-healthy eating plan—can improve quality of life for adults whose asthma is not well controlled by medication. Participants are randomly assigned to either a DASH-focused behavioral coaching program or standard asthma…
Phase: PHASE2, PHASE3 • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Triple-drug inhaler aims to tame severe asthma in teens and adults
Disease control CompletedThis study tests whether a three-in-one inhaler (budesonide, glycopyrronium, and formoterol) works better than two-drug inhalers for people aged 12 to 80 with asthma that is not well controlled by their current treatment. Participants receive either the triple inhaler, a two-drug…
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Skin test may personalize asthma care for kids
Disease control CompletedThis study tests whether a skin test that measures histamine response can help doctors decide if adding an antihistamine (Levocetirizine) to standard asthma treatment improves control in children aged 6-17 with allergic asthma. About 300 African American/Black and Caucasian/White…
Phase: PHASE3 • Sponsor: Bridgette Jones • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Triple-drug inhaler aims to tame severe asthma in teens and adults
Disease control CompletedThis study tests whether a three-in-one inhaler (budesonide, glycopyrronium, and formoterol) works better than two standard two-drug inhalers for people with asthma that is not well controlled. Adults and adolescents aged 12 to 80 with moderate-to-severe asthma will use the tripl…
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New triple inhaler aims to tame tough asthma
Disease control CompletedThis study tested a new inhaler that combines three medicines (beclometasone, formoterol, and glycopyrronium) against a standard two-medicine inhaler in over 1,100 adults with asthma that was not well controlled. The goal was to see if the triple combination improves lung functio…
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
New triple inhaler shows promise for uncontrolled asthma
Disease control CompletedThis study tested a new inhaler that combines three medicines (beclometasone, formoterol, and glycopyrronium) in people whose asthma was not well controlled with standard two-medication inhalers. Over 1,400 adults took part for 52 weeks. The triple inhaler improved lung function …
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Video chats boost asthma med adherence in young patients
Disease control CompletedThis study tested whether video-based medication coaching helps adolescents and young adults with uncontrolled asthma take their inhaled steroids more regularly. 375 participants received either standard care or telehealth sessions to improve medication use. The goal was to see i…
Phase: NA • Sponsor: Johns Hopkins University • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Giving asthma meds at school could keep kids healthier and in class
Disease control CompletedThis study tested a program where children with asthma receive their daily preventive medication at school, along with education and check-ups. The goal was to reduce asthma symptoms, emergency visits, and missed school days. The study included 29 children enrolled in a school-ba…
Phase: NA • Sponsor: State University of New York at Buffalo • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Can swimming and breathing training help kids with asthma?
Disease control CompletedThis study looked at whether adding special breathing muscle training to a swimming program could improve asthma control in children with mild asthma. Thirty children aged 8-11 took part in a 4-week swimming program, with half also doing breathing exercises twice daily. Researche…
Phase: NA • Sponsor: Gümüşhane Universıty • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Can breathing exercises tame childhood asthma?
Disease control CompletedThis study looked at whether the Buteyko breathing technique can help control asthma and improve quality of life in children aged 7 to 12. Sixty-five children with asthma participated, learning specific breathing exercises. The goal was to see if this non-drug approach could redu…
Phase: NA • Sponsor: Cukurova University • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New asthma drug JYB1904 shows promise in early trial
Disease control CompletedThis study tested a new drug, JYB1904, in 69 adults with allergic asthma. Participants received either JYB1904 every 8 weeks or the standard drug omalizumab every 2 to 4 weeks for 24 weeks. The goal was to see how the drug behaves in the body, how safe it is, and how well it cont…
Phase: PHASE2 • Sponsor: Jemincare • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Asthma drug roflumilast tested for Long-Term safety in new study
Disease control CompletedThis study looked at the long-term safety of the drug roflumilast in adults with asthma. Participants had already finished a 24-week study and took the drug once daily for another 28 weeks. The goal was to see if the drug remained safe over a longer period.
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
New asthma pill shows promise in major trial
Disease control CompletedThis study tested a daily pill called roflumilast (APTA-2217) to see if it improves lung function in adults with asthma. About 450 participants took either the drug or a placebo for 24 weeks. Researchers measured breathing tests, asthma symptoms, and side effects to evaluate safe…
Phase: PHASE2, PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Can a chatbot help people with asthma breathe easier?
Disease control CompletedThis study tested whether a smartphone chatbot called Vik-Asthme can teach adults with asthma how to manage their condition as well as the usual in-person training. 73 adults with asthma were split into two groups: one received standard education, the other used the chatbot. Rese…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New study: which rescue inhaler cuts asthma attacks better?
Disease control CompletedThis study looked at over 4,000 people with asthma to see if Airsupra works better than albuterol at preventing severe asthma attacks in everyday life. Researchers reviewed medical records to compare how often attacks happened and how long it took for the first attack to occur. T…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Fish oil shows promise for Tough-to-Treat asthma
Disease control CompletedThis study tested whether taking high-dose fish oil (n-3 PUFA) for 6 months can improve asthma control in adults with a specific type of asthma called N-ERD, which is triggered by aspirin or NSAIDs. The 18 participants had poorly controlled asthma despite standard treatment. The …
Phase: PHASE3 • Sponsor: Norfolk and Norwich University Hospitals NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New hope for teens with severe asthma? dupilumab under the microscope
Disease control CompletedThis study followed 105 teenagers with severe uncontrolled asthma who were starting treatment with dupilumab (Dupixent). Researchers tracked their asthma control, flare-ups, and safety over one year. The goal was to see if this medication helps teens manage their condition better…
Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New asthma drug shows promise in early safety trial
Disease control CompletedThis early-stage trial tested a drug called itolizumab (EQ001) in 18 adults with moderate-to-severe asthma that is not well controlled by standard treatments. The main goal was to see if the drug is safe and how the body processes it. Researchers also looked for early signs that …
Phase: PHASE1 • Sponsor: Biocon Limited • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New antibody drug shows promise for blocking asthma attacks
Disease control CompletedThis phase II trial tested a drug called huMAb OX40L in 29 adults with mild allergic asthma. The drug is an antibody designed to block a protein that triggers allergic reactions in the airways. Researchers measured whether it could prevent breathing problems caused by allergens, …
Phase: PHASE2 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
New asthma shot depemokimab tested in chinese volunteers
Disease control CompletedThis early-stage study tested a single shot of depemokimab, a biologic drug for asthma, in 20 healthy Chinese adults. Researchers measured how the drug moves through the body and checked for side effects. The goal was to gather safety and dosing information for future studies in …
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New asthma shot could match leading biologics in preventing severe attacks
Disease control CompletedThis study tested whether switching to a new drug called depemokimab (GSK3511294) works as well as staying on current treatments (mepolizumab or benralizumab) for people with severe asthma linked to high eosinophils. Over 1,700 adults and teens took part for 52 weeks, continuing …
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
88% of patients with asthma and nasal polyps achieve dual remission on dupilumab
Disease control CompletedThis study looked at 28 adults with both severe asthma and chronic sinusitis with nasal polyps who were treated with dupilumab for 24 months. The goal was to see if the drug could help control both conditions at the same time, called 'dual remission.' After 24 months, 88% of pati…
Sponsor: Azienda Ulss 2 Marca Trevigiana • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Can one inhaler do it all for asthma? new study tests simpler approach
Disease control CompletedThis study tested whether using Foster (a combination inhaler) for both daily maintenance and as-needed relief works better than using Foster daily plus a separate salbutamol rescue inhaler. Over 1,700 adults with not fully controlled asthma took part for 48 weeks. The main goal …
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
New drug verekitug aims to curb severe asthma attacks
Disease control CompletedThis study tested a new drug called verekitug (UPB-101) in 479 adults with severe asthma. The goal was to see if it could reduce asthma attacks and improve lung function compared to a placebo. Participants received either verekitug or a dummy injection over several months. The tr…
Phase: PHASE2 • Sponsor: Upstream Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New app aims to help hispanic kids breathe easier
Disease control CompletedThis study tested an app called Asma Guardián, designed to help Hispanic children with asthma. The app encourages families to see an asthma specialist, use controller medication, and improve the home environment. 37 children aged 5-12 took part, and the study compared app users t…
Phase: NA • Sponsor: University of Texas at Austin • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
New asthma combo shows promise in early trial
Disease control CompletedThis study tested whether adding a bronchodilator called glycopyrrolate bromide to a standard steroid inhaler (Qvar) helps people with uncontrolled asthma breathe better. 98 adults with asthma took either the combination or a placebo for 6 weeks, then switched. The main goal was …
Phase: PHASE2 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New asthma drug shows promise in real-world greek study
Disease control CompletedThis study followed 152 adults in Greece with severe eosinophilic asthma who were starting benralizumab, a medication that helps control severe asthma. Researchers measured not only standard asthma control but also quality of life, sleep, mood, and physical activity using wearabl…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Eco-Friendly asthma inhaler passes safety check in major trial
Disease control CompletedThis study tested a new, environmentally friendly propellant (HFA-152a) in a common asthma inhaler (CHF5993) to see if it is as safe as the current propellant. Over 800 adults with moderate to severe asthma used the inhaler twice daily for 12 weeks. The main goal was to check for…
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New inhaler combo shows promise for Hard-to-Control asthma
Disease control CompletedThis study tested whether adding a drug called glycopyrrolate to a standard asthma inhaler (Foster) helps people whose asthma is not well controlled. 211 adults with uncontrolled asthma took part. The main goal was to see if the combination improved lung function over 12 hours. T…
Phase: PHASE2 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New school program aims to get kids with asthma moving more
Disease control CompletedThis study tested a school-based program called Asthma-PASS to help children with asthma be more physically active. The program worked with doctors, community health workers, and schools to ensure kids had the right medications and could use rescue inhalers at school. Researchers…
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New asthma drug shows promise in reducing severe attacks
Disease control CompletedThis Phase 2 trial tested amlitelimab, an injectable drug, in 437 adults with moderate-to-severe asthma. Participants received either amlitelimab or a placebo alongside their usual asthma medications. The study measured how well the drug reduced severe asthma attacks and improved…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New asthma study aims to match treatments to patients
Disease control CompletedThis completed Phase 2 trial tested several different drugs in 950 people with severe asthma. The goal was to see which treatments improve lung function and control symptoms. Participants tried each treatment for 16 weeks, with breaks in between, to find the best match for their …
Phase: PHASE2 • Sponsor: University of North Carolina, Chapel Hill • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Real-World study checks if benralizumab tames severe asthma in taiwan
Disease control CompletedThis study looked at 43 adults in Taiwan with severe eosinophilic asthma who were already prescribed benralizumab. Researchers tracked changes in asthma control using a standard questionnaire over time. The goal was to see how well the drug works in everyday medical practice, not…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New hope for asthma and polyp sufferers? mepolizumab under the microscope
Disease control CompletedThis study looked at whether the drug mepolizumab can improve symptoms in people with a specific combination of asthma, nasal polyps, and sensitivity to aspirin or similar painkillers. 95 adults received either mepolizumab or a placebo injection every month for 16 weeks. Research…
Phase: PHASE4 • Sponsor: Helsinki University Central Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can a phone app tame asthma? UK pilot study tests digital platform
Disease control CompletedThis pilot study tested a digital health platform that combines a smartphone app and connected inhaler sensors to help people with asthma track their medication use and technique. 94 adults with uncontrolled moderate-to-severe asthma in the UK used the platform for 6 months. The …
Phase: NA • Sponsor: CoheroHealth • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New asthma drug shows promise in reducing attacks
Disease control CompletedThis Phase 2b study tested lunsekimig, an injectable drug, in 685 adults with moderate-to-severe asthma. Participants received either lunsekimig or a placebo alongside their usual asthma medications. The goal was to see if lunsekimig could reduce asthma attacks and improve breath…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New combo inhaler breathes better for tough asthma cases
Disease control CompletedThis study tested whether a combination inhaler (CHF 1535, containing both a steroid and a long-acting bronchodilator) works better than a steroid-only inhaler in adults whose asthma is not well controlled despite high-dose steroids or medium-dose steroids plus another bronchodil…
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Smart inhaler app aims to help asthma patients breathe easier
Disease control CompletedThis study tested a digital system that includes a smart inhaler, a phone app, and a dashboard for doctors to help people with asthma better manage their condition. Over 12 weeks, 333 participants aged 13 and older used either the smart system or their usual rescue inhaler. The g…
Phase: PHASE4 • Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Real-World study shows tezepelumab helps tame severe asthma
Disease control CompletedThis study looked at how well the drug tezepelumab works for people with severe asthma when used in real-world settings, not just in controlled trials. Over 500 participants aged 12 and older were followed after starting tezepelumab. The main goal was to see if their asthma sympt…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Asthma drug benralizumab put to the test in everyday life
Disease control CompletedThis study looked at how well benralizumab (Fasenra) works for people with severe eosinophilic asthma in real-world clinics across the Gulf, Latin America, and India. Researchers tracked 291 patients to see if their asthma control improved over time using a standard questionnaire…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New inhaler shows promise for cutting asthma attacks in high-risk patients
Disease control CompletedThis study tested an experimental inhaled drug called AZD8630 in 537 adults whose asthma is not well controlled despite using standard inhalers. Participants took the drug or a placebo once daily for 12 weeks. The goal was to see if the drug could reduce asthma flare-ups and impr…
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
New combo inhaler may tame asthma inflammation better than standard rescue puffers
Disease control CompletedThis completed Phase 4 trial tested whether a combination inhaler (AIRSUPRA, containing albuterol and budesonide) works better than albuterol alone for adults with mild asthma. Over 12 weeks, researchers measured airway inflammation, daily symptoms, and how often participants nee…
Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Village health workers cut deaths in remote indian tribes
Disease control CompletedThis large study in rural India trained village health workers to diagnose and treat common illnesses like high blood pressure, diarrhea, pneumonia, malaria, asthma, and COPD. Over 72,000 adults aged 16-60 from 80 tribal villages took part. The goal was to reduce deaths by at lea…
Phase: PHASE4 • Sponsor: MAHAN Trust • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New allergy shots show promise for dust mite sufferers
Disease control CompletedThis study tested a type of allergy immunotherapy (Clustoid® Max Forte) in 140 people aged 5 to 65 with dust mite allergies. The goal was to see if it reduces allergy and asthma symptoms and the need for medication over one year. Results were measured by symptom scores and medica…
Sponsor: Inmunotek S.L. • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New clinic program aims to tackle multiple chronic diseases in south africa
Disease control CompletedThis completed study tested a health system intervention called ENHANCE in 1,837 adults aged 40+ with at least two chronic conditions (HIV, high blood pressure, diabetes, asthma, or depression). The intervention included a clinical decision support tool for clinicians, health edu…
Phase: NA • Sponsor: University of KwaZulu • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Asthma inhaler switch may help patients breathe easier, study finds
Disease control CompletedThis study looked at 620 adults with asthma that was not well controlled on their current treatment. They were given a combination inhaler (beclometasone/formoterol) to use daily. After 6 months, researchers measured how many patients improved their asthma control using a standar…
Sponsor: Chiesi Italia • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Dietary supplement shows promise for controlling kids' asthma and allergy symptoms
Disease control CompletedThis study tested a dietary supplement containing immune-supporting nutrients and postbiotics in 40 children aged 5–12 with asthma and/or allergic rhinitis. The goal was to see if the supplement could improve symptom control over 6 months. Researchers also looked at changes in im…
Phase: NA • Sponsor: Federico II University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Social media prescribed for asthma: study tests if facebook and instagram can cut hospital visits
Disease control CompletedThis pilot study tested whether adding asthma education through social media platforms like Facebook, Twitter, Instagram, and Snapchat could reduce hospital visits, emergency room trips, and clinic appointments for children with asthma. Two hundred children hospitalized for asthm…
Phase: NA • Sponsor: The University of Texas Health Science Center, Houston • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Can online care help kids with asthma breathe easier?
Disease control CompletedThis study tested whether virtual care—online education, case management, and symptom tracking—can help children with asthma better manage their condition and improve quality of life. 97 children and their families used an asthma diary and sent updates every 4 weeks. The goal was…
Phase: NA • Sponsor: Ege University • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Real-World FASENRA study completed in korea: safety under the microscope
Disease control CompletedThis completed study looked at the safety and effectiveness of FASENRA (benralizumab) in 51 Korean adults with severe eosinophilic asthma or eosinophilic granulomatosis with polyangiitis (EGPA). Researchers tracked side effects and how well the drug controlled symptoms during rou…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New asthma injection shows promise in early trial
Disease control CompletedThis early-phase study tested a new drug called RC1416 in 40 adults with moderate to severe asthma. Participants received a single injection of either the drug or a placebo. The main goal was to check safety and how the body processes the drug, with a preliminary look at whether …
Phase: PHASE1 • Sponsor: Nanjing RegeneCore Biotech Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New asthma inhaler combo shows promise in large trial
Disease control CompletedThis study tested a new inhaler containing two medicines (budesonide and formoterol) in 645 people aged 12 to 80 with asthma that was not well controlled. The trial compared the new inhaler to a standard budesonide-only inhaler and an existing combination inhaler over 24 weeks. T…
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New combo inhaler aims to stop asthma attacks faster
Disease control CompletedThis completed Phase 3 trial tested whether a combination inhaler containing albuterol and budesonide (PT027) works better than albuterol alone (PT007) for treating sudden asthma attacks. 190 adults with asthma who only used rescue inhalers as needed took part. Researchers measur…
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Can an ectoin inhaler tame mild asthma?
Disease control CompletedThis study tested an inhaled solution of Ectoin, a natural substance, in 18 adults with mild asthma. The goal was to find a safe dose and see if it reduces airway sensitivity. Participants inhaled different doses over short periods, and results were compared to a placebo. The stu…
Phase: NA • Sponsor: Bitop AG • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New combo inhaler shows promise for Hard-to-Control asthma
Disease control CompletedThis study tested whether a combination inhaler containing both an anti-inflammatory steroid (budesonide) and a fast-acting bronchodilator (formoterol) works better than the steroid alone for people whose asthma is not well controlled. 374 adults and adolescents took part over 12…
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Real-world study confirms mepolizumab cuts asthma attacks and steroid use
Disease control CompletedThis study followed 106 adults with severe eosinophilic asthma in Poland who received mepolizumab injections every 4 weeks for at least a year. Researchers tracked asthma attacks and the need for oral steroids before and during treatment. The goal was to see if the drug helps con…
Sponsor: Medical University of Lodz • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New asthma pill shows promise in early trial
Disease control CompletedThis study tested a daily pill called atuliflapon in 670 adults with moderate to severe asthma that is not well controlled by current treatments. The goal was to see if the drug could reduce asthma flare-ups over 12 weeks compared to a placebo. The trial is now complete, and resu…
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New asthma drug shows promise in Long-Term safety check
Disease control CompletedThis study looked at the long-term safety of a drug called depemokimab in 641 adults and teenagers with severe asthma caused by a type of white blood cell called eosinophils. Participants had already completed earlier studies and received the drug for another 12 months. The main …
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Can a smartphone app help people with asthma breathe easier?
Disease control CompletedThis study tested whether a mobile health app, paired with a Bluetooth-enabled peak flow meter, could help people with asthma track their breathing. 83 adults with asthma, including some who were pregnant, used the app to measure their lung function. The goal was to see if this a…
Sponsor: Linnea Polgreen • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New asthma pill shows promise in large trial
Disease control CompletedThis study tested whether adding a daily pill called QAW039 to standard asthma treatments helps people with uncontrolled asthma breathe better. Over 700 adults and teens took either QAW039 or a placebo for 12 weeks. The main goal was to see if lung function (measured by how much …
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New asthma inhaler shows promise in large trial
Disease control CompletedThis study tested a new inhaler called QMF149, which combines two drugs (indacaterol and mometasone), against a standard steroid inhaler (mometasone alone) in 802 adults and teens with mild asthma. The goal was to see if the combination improved lung function and symptom control …
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New asthma pill shows promise in large trial
Disease control CompletedThis study tested whether a daily pill called QAW039 can help people with uncontrolled asthma breathe better. 675 adults and teens took either the drug or a placebo for 12 weeks, on top of their usual inhalers. The main goal was to see if lung function improved.
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Home workouts may ease asthma symptoms, small study suggests
Disease control CompletedThis study tested an 8-week home-based pulmonary rehabilitation program for adults with asthma. The program included stretching, strengthening, breathing exercises, and walking, using simple equipment found at home. Researchers measured changes in lung function, exercise capacity…
Phase: NA • Sponsor: Bezmialem Vakif University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Could dupilumab help Hard-to-Treat asthma patients?
Disease control CompletedThis study looked at whether dupilumab, a drug that blocks certain immune signals, can reduce signs of autoimmunity in the airways of people with severe asthma. 30 patients were followed for 4 months. The goal was to see if this approach could help those who don't get better with…
Sponsor: McMaster University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New asthma drug shows promise in small trial
Disease control CompletedThis study tested tezepelumab, a monoclonal antibody, in 27 adults with uncontrolled moderate-to-severe asthma. The goal was to see if it improves lung function and reduces airway inflammation and blockages. Participants received either tezepelumab or a placebo, and researchers u…
Phase: PHASE3 • Sponsor: McMaster University • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New asthma drug candidate PA9159 passes first safety check in healthy volunteers
Disease control CompletedThis early-stage study tested a new asthma medication called PA9159, given as an inhaled aerosol, in 40 healthy adults in China. The main goal was to see if it is safe and how the body processes it. Researchers monitored side effects, vital signs, and lab tests after single and r…
Phase: PHASE1 • Sponsor: Anhui Palo Alto Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Exercise dose matters for obese kids with asthma
Disease control CompletedThis study looked at how different amounts of aerobic exercise affect body fat, inflammation, and lung function in obese children with asthma. 72 children aged 8-18 were split into groups doing less than 75, 150, or 300 minutes of weekly exercise for 12 weeks. Researchers measure…
Phase: NA • Sponsor: Cairo University • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Teens with asthma learn to breathe easier with peer-led tech program
Disease control CompletedThis study tested whether a technology-based education program, delivered by peer mentors or adult educators, helps teenagers aged 14-17 with asthma. 48 teens were split into two intervention groups and a control group. The program aimed to improve asthma control, quality of life…
Phase: NA • Sponsor: Bartın Unıversity • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
New shot shows promise for teen asthma
Disease control CompletedThis study tested a single injection of a new drug called SHR-1905 in 9 teenagers with asthma. The goal was to see how the drug moves through the body, if it is safe, and if it helps control asthma. Participants were aged 12 to 17, had asthma for at least 6 months, and were on st…
Phase: PHASE2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New asthma drug TR4 enters first human tests
Disease control CompletedThis early-stage study tested a new drug called TR4 in 12 adults with mild-to-moderate asthma. TR4 is a beta-2 blocker, which works differently than typical asthma treatments. The main goal was to see if it is safe and tolerable, and to measure its effects on lung function and ai…
Phase: PHASE1 • Sponsor: Trio Medicines Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New asthma drug could let patients ditch daily steroid pills
Disease control CompletedThis study tested a drug called tezepelumab in 305 adults with severe asthma who were already taking daily steroid pills. The goal was to see if tezepelumab could help them safely reduce or stop their oral steroids without losing asthma control. Participants received tezepelumab …
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Asthma drug levels tested in teens: will it work the same as in adults?
Disease control CompletedThis study looked at how much of the asthma drug CHF 6001 gets into the blood of teenagers compared to adults after a single inhaled dose. Fifty people with asthma took part, including teens aged 12 to 17 and adults up to 75 years old. The goal was to see if the drug behaves simi…
Phase: PHASE2 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Asthma drug dupilumab tested for Long-Term safety in kids
Disease control CompletedThis study followed 378 children with asthma who had already taken dupilumab in an earlier trial. Researchers wanted to see if the drug is safe and tolerable over a full year. They also measured how well it controls asthma symptoms. The goal was to make sure long-term use is safe…
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New antibody drug shows promise for severe asthma sufferers
Disease control CompletedThis study tested an experimental drug called TQC2731 in 205 adults with severe asthma that is not well controlled by standard treatments. The drug is a lab-made antibody that blocks a protein involved in asthma inflammation. Participants received either one of three doses of TQC…
Phase: PHASE2 • Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
ER-to-School asthma program aims to keep kids out of the hospital
Disease control CompletedThis study tested a new way to help children with asthma take their medicine properly. Kids who came to the emergency room for an asthma attack were given their medications right there, and then school staff supervised their daily use. The goal was to see if this approach could r…
Phase: PHASE4 • Sponsor: University of Arizona • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New asthma drug shows promise in early trial
Disease control CompletedThis study tested an experimental inhaled drug called AZD4604 in 339 adults with moderate-to-severe asthma that remains uncontrolled despite standard treatment. Participants took the drug or a placebo twice daily for 12 weeks. The main goal was to see if the drug could reduce ast…
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Rural patients get Hospital-Level care at home in landmark trial
Disease control CompletedThis study looked at whether giving hospital-level care to acutely ill adults in their own homes in rural areas works well. 160 people with various conditions like infections, heart failure, or COPD took part. The goal was to see if this approach could lower costs and help patien…
Phase: NA • Sponsor: Brigham and Women's Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
New asthma drug shows promise in reducing airway inflammation
Disease control CompletedThis study tested a new drug called AZD4604 in 36 adults with moderate-to-severe asthma. The goal was to see if it reduces airway inflammation and affects certain genes over a 4-week treatment period. Participants took either the drug or a placebo, and researchers measured change…
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Tech tool boosts asthma care for city kids
Disease control CompletedThis study tested a computer-based program that reminds doctors to follow asthma guidelines for children aged 2 to 12 with persistent or uncontrolled asthma. The program helped doctors take more corrective actions, like adjusting medication or checking triggers. The goal was to r…
Phase: NA • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Head-to-Head: which biologic works best for nasal polyps and asthma?
Disease control CompletedThis completed phase 4 trial directly compared two injectable drugs, dupilumab (Dupixent) and omalizumab (Xolair), in 360 adults with severe chronic rhinosinusitis with nasal polyps and asthma. The main goals were to see which drug better reduced polyp size and improved sense of …
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New asthma drug cuts severe attacks in Hard-to-Treat patients
Disease control CompletedThis study tested a drug called tezepelumab in 287 adults and teens with severe asthma, including groups often left out of research. The goal was to see if the drug reduces asthma attacks and is safe over 52 weeks. Results showed fewer flare-ups compared to the year before starti…
Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New asthma drug shows promise in Real-World spanish study
Disease control CompletedThis study looked at how well tezepelumab works for people with severe asthma when used in everyday medical practice, outside of a clinical trial. Researchers tracked 33 patients in Spain who received the drug through a special access program. The goal was to see how the drug aff…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New asthma drug shows promise in taming tough coughs
Disease control CompletedThis study tested the drug tezepelumab in 92 adults with severe asthma to see if it improves asthma control and reduces chronic cough. Participants took the drug as prescribed by their doctor, and researchers tracked their symptoms and quality of life for a year. The goal was to …
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Daily vitamin d may slash lung risks in kids with sickle cell disease
Disease control CompletedThis study tested whether taking vitamin D every day could reduce lung complications in children and teens with sickle cell disease. Lung problems like infections, asthma attacks, and acute chest syndrome are major causes of illness and death in this condition. Researchers gave d…
Phase: PHASE2 • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Helping Mom's mood may help Kid's asthma
Disease control CompletedThis study looked at 205 pairs of caregivers with major depression and their children (ages 7-17) with asthma. Caregivers could choose to take standard antidepressant medication or not. Researchers tracked changes in the caregiver's depression and the child's asthma control over …
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can salmon oil tame asthma? new study investigates
Disease control CompletedThis study tested whether a salmon oil supplement called CARDIO® could help control asthma in adults. 70 participants took either the supplement or a placebo alongside their usual asthma medications. The goal was to see if the supplement reduced asthma attacks and improved breath…
Phase: NA • Sponsor: Hofseth Biocare ASA • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Can telemedicine at school tame Kids' asthma?
Disease control CompletedThis study tested a program called TEAM-UP that brings asthma specialist visits to children at school via telemedicine, combined with daily preventive medication given at school. 326 children aged 4-12 with moderate to severe asthma took part. The goal was to see if this approach…
Phase: NA • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 26, 2026 18:36 UTC
-
Can a smartphone program get teens to use their asthma inhalers?
Disease control CompletedThis study tested a stepped-care program called TASC to help teenagers with moderate to severe asthma stick to their daily inhaler routine. 72 teens were randomly assigned to either the program or usual care. The program starts with simple reminders and steps up to more support i…
Phase: NA • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 26, 2026 18:30 UTC
-
Nasal spray shows promise for tough asthma in early trial
Disease control CompletedThis study tested an experimental nasal spray called AD17002 in 40 adults with poorly controlled moderate-to-severe eosinophilic asthma. Participants self-administered the spray twice a week for six weeks. The goal was to see if it could improve lung function and reduce the need …
Phase: PHASE1, PHASE2 • Sponsor: Advagene Biopharma Co. Ltd. • Aim: Disease control
Last updated Jun 26, 2026 16:35 UTC
-
Gene-Guided reflux drug may tame childhood asthma
Disease control CompletedThis study tested whether adjusting the dose of a common acid reflux medicine (lansoprazole) based on a child's genes could improve asthma control. 41 children aged 6-17 with uncontrolled asthma and mild reflux participated. Researchers measured changes in asthma symptoms and ref…
Phase: PHASE3 • Sponsor: Jason Lang, M.D., M.P.H. • Aim: Disease control
Last updated Jun 26, 2026 15:11 UTC
-
Asthma drug dupilumab targets lung mucus in new imaging study
Disease control CompletedThis study tested dupilumab (Dupixent) in 109 adults with uncontrolled moderate-to-severe asthma. Researchers used lung scans and breathing tests to see if the drug reduces airway inflammation and mucus plugging. Participants received either dupilumab or a placebo for 24 weeks. T…
Phase: PHASE4 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 15:05 UTC
-
Virtual Check-Ups after ER visits could help kids with asthma breathe easier
Disease control CompletedThis study tested a telemedicine program to help children with asthma get better follow-up care after an emergency room visit. The program included a video visit at school within a week of discharge, plus two more check-ins. Researchers measured how many symptom-free days childre…
Phase: NA • Sponsor: University of Rochester • Aim: Disease control
Last updated Jun 26, 2026 14:20 UTC
-
New combo inhaler shows promise for better asthma control in large trial
Disease control CompletedThis study tested whether a combination inhaler containing both an anti-inflammatory steroid (beclomethasone) and a fast-acting bronchodilator (formoterol) works better than a steroid-only inhaler for adults with asthma. Over 1,300 participants on medium or high-dose steroids too…
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Disease control
Last updated Jun 26, 2026 13:39 UTC
-
Fasenra proven safe for Long-Term asthma control in Real-World study
Disease control CompletedThis study looked at the long-term safety and effectiveness of Fasenra (benralizumab) in 653 people with severe asthma that wasn't controlled by other treatments. Researchers tracked side effects and asthma control over time. The goal was to confirm that Fasenra works well and is…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 26, 2026 12:33 UTC
-
New MRI technique could spare asthma patients from radiation
Diagnosis CompletedThis study tested whether a special MRI technique can measure airway thickness in asthma patients as well as CT scans do, but without radiation. Thirty adults with asthma underwent both scans. The goal is to find a safer way to monitor airway changes over time.
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Diagnosis
Last updated Jun 27, 2026 13:04 UTC
-
Breath test could revolutionize asthma diagnosis
Diagnosis CompletedThis study looked at a new, non-invasive test to identify asthma patients with high levels of an enzyme called GSNOR, which can cause airway swelling. The test involves inhaling a substance called GSNO and measuring changes in breath and lung function. Researchers hope this offic…
Phase: EARLY_PHASE1 • Sponsor: James Reynolds • Aim: Diagnosis
Last updated Jun 27, 2026 12:36 UTC
-
Race Walkers' breathing under the microscope: altitude study reveals hidden lung strain
Diagnosis CompletedThis study looked at whether training at high altitudes causes or worsens exercise-induced bronchoconstriction (EIB) in 64 elite race walkers. Participants completed lung function tests, treadmill challenges, and blood draws at both low and high altitudes over 2-4 months. The goa…
Sponsor: Shanghai University of Sport • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
New study tests quick, portable tools to diagnose asthma without hospital visits
Diagnosis CompletedThis study looked at two simple tests—a breath test (FeNO) and a blood test (eosinophil count)—to see if they can diagnose asthma more easily than current hospital-based breathing tests. Researchers studied 123 people aged 12 and older with suspected asthma. The goal was to find …
Sponsor: Université de Sherbrooke • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC
-
Breathing cold air may reveal asthma better than current tests
Diagnosis CompletedThis study tested a cold air breathing challenge in 60 adults (some with asthma, some healthy) to see if it can safely tell the difference between asthma and normal lungs. Researchers measured lung function and symptoms after the test. The goal is to develop a more reliable tool …
Phase: NA • Sponsor: KU Leuven • Aim: Diagnosis
Last updated Jun 27, 2026 07:55 UTC
-
Monthly capsule may keep wheezing away in babies at risk
Prevention CompletedThis study tested whether a monthly oral bacterial extract (Broncho-Vaxom) could prevent wheezing lower respiratory tract infections in infants aged 6-18 months who are at high risk for asthma. Over 800 participants received either the extract or a placebo for 10 days each month …
Phase: PHASE2 • Sponsor: University of Arizona • Aim: Prevention
Last updated Jun 27, 2026 13:00 UTC
-
Salmon plant study aims to stop asthma before it starts
Prevention CompletedThis study looked at ways to reduce breathing problems and allergies in over 1,100 Norwegian salmon industry workers. The goal was to find practical changes in the workplace that lower workers' exposure to dust and other particles that can cause asthma. Researchers measured air q…
Phase: NA • Sponsor: University Hospital of North Norway • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
Vitamin d in pregnancy fails to prevent asthma in kids
Prevention CompletedThis study tested whether giving pregnant women daily vitamin D supplements (4000 IU) could prevent asthma or recurrent wheezing in their children during the first three years of life. The trial enrolled 876 pregnant women with a personal or family history of asthma or allergies.…
Phase: PHASE3 • Sponsor: Brigham and Women's Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:32 UTC
-
Can learning to cope help kids breathe easier?
Symptom relief CompletedThis study tested a program that teaches coping skills and asthma management to Latino children with asthma and their families. The goal was to see if reducing stress could improve asthma control and quality of life. 282 children aged 8-14 took part, comparing the combined progra…
Phase: NA • Sponsor: Erin M Rodriguez • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
Breathing exercises show promise for asthma patients with breathing problems
Symptom relief CompletedThis study looked at whether breathing exercises can improve quality of life for adults with asthma who also have dysfunctional breathing (a pattern of breathing that causes shortness of breath). About 190 adults with poorly controlled asthma took part. Half received usual care, …
Phase: NA • Sponsor: Naestved Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New asthma drug candidate IBI3002 begins first human safety tests
Symptom relief CompletedThis early-stage study tested the safety of a new drug called IBI3002 in 40 healthy volunteers and 20 people with asthma. Participants received either the drug or a placebo, and researchers monitored for side effects. The goal was only to check if the drug is safe enough to study…
Phase: PHASE1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New inhaler coach could help COPD and asthma patients breathe easier
Symptom relief CompletedThis study tested a device that teaches people with COPD or asthma how to use their inhalers correctly. About 140 adults aged 18-85 who already use specific inhalers will be trained with either the device or standard brief instruction. The goal is to see if the device improves in…
Phase: NA • Sponsor: Koronis Biomedical Technologies • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
Heat therapy for lungs shows promise in severe asthma
Symptom relief CompletedThis study tested a procedure called bronchial thermoplasty for people with severe asthma that is not controlled by standard treatments. The treatment uses heat to thin the airway muscles, aiming to reduce breathlessness during exercise. 14 participants were enrolled, and the mai…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Belly band boosts breathing in asthma patients, small study finds
Symptom relief CompletedThis study tested whether wearing an abdominal binder (a supportive wrap around the belly) along with doing special breathing exercises could help people with asthma feel less breathless and improve their quality of life. Thirty-two adults with mild to moderate asthma took part o…
Phase: NA • Sponsor: Foundation University Islamabad • Aim: Symptom relief
Last updated Jun 27, 2026 12:38 UTC
-
Breathing training may ease asthma symptoms during exercise
Symptom relief CompletedThis study tested whether a special breathing exercise, called flow-resistive inspiratory muscle training, could reduce the severity of exercise-induced bronchoconstriction (EIB) in athletes with asthma. Fifteen competitive cyclists or athletes aged 18-35 completed the training a…
Phase: NA • Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 12:31 UTC
-
Can simple exercises help asthmatics breathe easier?
Symptom relief CompletedThis study compared two non-drug approaches—posture correction exercises and the Papworth breathing technique—in 38 adults with mild to moderate asthma and forward head posture. The goal was to see which method better reduced shortness of breath, improved chest expansion, and enh…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
Nebulizer vs inhaler: which delivers asthma relief faster?
Symptom relief CompletedThis study tested two methods of giving salbutamol (a common asthma rescue drug) to 16 adults with mild asthma. One method used a vibrating mesh nebulizer, the other a standard inhaler with a spacer. The goal was to see which one reversed airway narrowing faster and more complete…
Phase: PHASE4 • Sponsor: University of Saskatchewan • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Could ambulance asthma treatment keep kids out of the hospital?
Symptom relief CompletedThis pilot study tested whether giving two asthma medications (ipratropium and dexamethasone) to children during ambulance transport can reduce hospital admissions. The study included 44 children aged 2 to 17 with severe wheezing. The goal was to see if this early treatment is fe…
Phase: PHASE2 • Sponsor: Oregon Health and Science University • Aim: Symptom relief
Last updated Jun 27, 2026 12:24 UTC
-
Could a Mucus-Busting drug help Hard-to-Treat asthma?
Symptom relief CompletedThis small pilot study tested whether inhaling a drug called rhDNAse every day for 4 weeks could help adults with neutrophilic asthma, a type of asthma that often doesn't respond well to standard treatments. The drug works by breaking down DNA in lung mucus, making it thinner and…
Phase: PHASE1, PHASE2 • Sponsor: National Jewish Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Can old drugs ease bladder and asthma symptoms in liver disease?
Symptom relief CompletedThis study looked at whether two drugs, mirabegron and montelukast, are safe and helpful for people with liver cirrhosis who also have overactive bladder and asthma. 78 participants took part over 3 months. Researchers tracked bladder symptoms, breathing issues, and side effects …
Phase: PHASE4 • Sponsor: Kafrelsheikh University • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
App aims to ease asthma symptoms between checkups
Symptom relief CompletedThis study tested whether a mobile app that lets people with asthma report their symptoms between doctor visits can improve their quality of life. Over 400 adults with asthma used either the app or received usual care. Researchers measured changes in asthma-related quality of lif…
Phase: NA • Sponsor: RAND • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
New inhaled asthma drug shows promise in early trial
Symptom relief CompletedThis early-stage study tested an inhaled medication called ARO-RAGE in 127 healthy volunteers and people with asthma. The goal was to check safety and how the drug affects lung function. Participants received one or two doses of the drug or a placebo. Results will help decide if …
Phase: PHASE1, PHASE2 • Sponsor: Arrowhead Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
Simple stretches may improve breathing in asthma patients
Symptom relief CompletedThis study tested two types of exercises in 54 adults with chronic asthma: one that stretches the upper back and one that pulls the shoulder blades back. The goal was to see if these exercises could improve chest expansion, lung function, and shortness of breath. Participants did…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
New app helps teens breathe easier by managing asthma together with parents
Symptom relief CompletedThis study tested a mobile app called AIM2ACT that helps teens aged 12-15 with poorly controlled asthma work with their caregivers to manage symptoms. The app includes daily check-ins, goal setting, and training videos. The goal was to see if using the app improves asthma control…
Phase: NA • Sponsor: University of Florida • Aim: Symptom relief
Last updated Jun 27, 2026 12:02 UTC
-
Cutting salt and sugar may tame steroid side effects
Symptom relief CompletedThis study looked at whether a diet low in salt and sugar can reduce common side effects of corticosteroid treatment, such as weight gain, high blood pressure, and diabetes. Fifty adults with autoimmune diseases or asthma who were starting high-dose corticosteroids were randomly …
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Pink or white? asthma inhaler color may influence symptom perception
Symptom relief CompletedThis study tested whether the color of an asthma inhaler (pink vs white) affects how people perceive their asthma symptoms. 78 adults with moderate to severe asthma used both colored inhalers and reported their symptoms daily. The goal was to see if the device color alone could c…
Phase: PHASE3 • Sponsor: Chiesi Farmaceutici S.p.A. • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Can a smartphone exercise program tame Hard-to-Control asthma?
Symptom relief CompletedThis pilot study tested whether a remote digital exercise program (Vitala app) is feasible and helpful for adults with obesity and poorly controlled asthma. Twenty participants received a tailored exercise prescription and were encouraged to complete 150 minutes of activity per w…
Phase: NA • Sponsor: University of Vermont • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Breathing exercises show promise for asthma relief
Symptom relief CompletedThis study tested two types of breathing exercises—diaphragmatic breathing and pursed-lip breathing—in 60 Egyptian adults with mild to moderate asthma. Participants did the exercises for 20 minutes twice a day, five days a week, for eight weeks. The goal was to see if these exerc…
Phase: NA • Sponsor: Ain Shams University • Aim: Symptom relief
Last updated Jun 27, 2026 11:03 UTC
-
New Real-World study tests triple inhaler for better asthma control
Symptom relief CompletedThis study followed 281 adults with asthma for 6 months to see if a triple-combination inhaler (BDP/FF/G) improves symptom control in everyday life. Participants had asthma for at least 3 years and were not well controlled on their current treatment. The main goal was to measure …
Sponsor: Chiesi Bulgaria • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
TRX workouts ease gut troubles in teen swimmers
Symptom relief CompletedThis study looked at whether an 8-week TRX exercise program could improve bowel habits and reduce stomach issues in competitive male swimmers aged 9 to 13. Thirty-two young athletes were split into two groups: one did TRX training plus swimming, the other only swam. Researchers m…
Phase: NA • Sponsor: Aksaray University • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
New asthma inhaler passes first safety check in small study
Symptom relief CompletedThis early-stage trial tested an experimental drug called SHR-4597, given as an inhaled powder, in 62 healthy volunteers and people with asthma. The main goal was to see if it is safe and tolerable. The study gave single doses to healthy people and multiple doses over several day…
Phase: PHASE1 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Nurse coaching boosts inhaler skills in asthma patients
Symptom relief CompletedThis study tested whether one-on-one training from a nurse could help people with asthma or COPD use their inhalers correctly. One hundred adults who already used inhalers took part. The goal was to see if the training improved their technique, knowledge, and how well they stuck …
Phase: NA • Sponsor: Mansoura University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Could a tiny dose of muscle relaxant make lung scopes safer?
Symptom relief CompletedThis study looked at whether giving a low dose of a muscle relaxant (rocuronium) during bronchoscopy—a procedure where a tube is inserted into the lungs—could reduce complications like throat spasms and coughing. 153 adults having elective bronchoscopy were split into two groups:…
Phase: NA • Sponsor: Harbin Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Breathing and yoga may ease asthma symptoms, small study finds
Symptom relief CompletedThis study looked at whether Papworth breathing (a slow, controlled breathing method) combined with Bridge Pose yoga could help people with asthma. 58 people aged 15-20 with mild to moderate asthma took part. One group did only Papworth breathing, while the other added Bridge Pos…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Asthma inhaler upgrade? new propellant passes safety check
Symptom relief CompletedThis study checked if a new propellant (HFA-152a) in salbutamol rescue inhalers is as safe as the current one (HFA-134a) for adults with asthma. 477 participants used the inhalers over time, and researchers tracked side effects. The goal was to ensure the new propellant is safe f…
Phase: PHASE3 • Sponsor: GlaxoSmithKline • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
Acupuncture put to the test for asthma relief
Symptom relief CompletedThis study tested whether acupuncture can improve asthma control in adults with mild-to-moderate persistent asthma. Two hundred participants were split into two groups: one received real acupuncture and the other received sham (fake) acupuncture, both over six weeks. The main goa…
Phase: NA • Sponsor: Shanghai University of Traditional Chinese Medicine • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
New ventilator mode may cut breathing tube time for lung disease patients
Symptom relief CompletedThis study tested a new ventilator mode called NAVA for people with chronic obstructive pulmonary disease (COPD) who need a breathing machine. NAVA uses the patient's own diaphragm signals to control the machine, aiming to improve comfort and reduce time on the ventilator. The st…
Phase: NA • Sponsor: Fu Jen Catholic University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:06 UTC
-
Steroid shot may ease asthma in kids with frequent attacks
Symptom relief CompletedThis study looked at how a steroid injection (triamcinolone acetonide) affects asthma symptoms in children aged 6 to 21 who have frequent flare-ups. 68 participants received the shot and were followed for 48 weeks. The main goal was to see if symptoms improved two weeks after the…
Phase: PHASE2 • Sponsor: Emory University • Aim: Symptom relief
Last updated Jun 27, 2026 09:05 UTC
-
Which asthma drug works best for kids? new study puts two to the test
Symptom relief CompletedThis study looked at 101 children aged 6 to 17 with moderate to severe asthma attacks in the emergency room. It compared two medications, racemic albuterol and levalbuterol, to see which one improved breathing better and reduced the need for hospital admission. The goal was to fi…
Phase: PHASE4 • Sponsor: Phoenix Children's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
New asthma inhaler propellant tested for safety in completed study
Symptom relief CompletedThis study tested whether a new propellant (HFO) in asthma inhalers causes airway narrowing (bronchospasm) compared to the standard propellant (HFA). It involved 52 adults with well-controlled or partially controlled asthma. Researchers measured lung function right after use and …
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Weekly reminders boost home monitoring in severe asthma patients
Symptom relief CompletedThis pilot study tested whether weekly reminder messages help adults with severe asthma stick to home-based lung function monitoring using a digital device. Thirty patients used the AioCare spirometry system for 12 weeks. Those who got reminders completed more monitoring sessions…
Phase: NA • Sponsor: University of Medicine and Pharmacy "Victor Babes" Timisoara • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
Can a breathing technique ease asthma fatigue?
Symptom relief CompletedThis study tested whether the Buteyko breathing technique, a method of controlled breathing, can reduce fatigue and improve exercise capacity and asthma control in people with asthma. 90 adults with a recent asthma diagnosis were split into two groups: one learned the Buteyko tec…
Phase: NA • Sponsor: University of Gaziantep • Aim: Symptom relief
Last updated Jun 27, 2026 08:12 UTC
-
Home exercises improve asthma symptoms in young adults
Symptom relief CompletedThis study looked at whether breathing and posture exercises, done at home through video calls, could help young adults with asthma. Twelve people aged 18-26 with stable asthma took part. The exercises aimed to improve breathing, posture, and quality of life. Results showed poten…
Phase: NA • Sponsor: Yeditepe University • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Simple stretches may ease asthma symptoms, small study finds
Symptom relief CompletedThis study tested two types of stretching exercises—thoracic cage stretching and intercostal stretching—in 56 adults with asthma. The goal was to see if these stretches could improve chest expansion, reduce shortness of breath, and increase oxygen levels. Participants did the str…
Phase: NA • Sponsor: Riphah International University • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
Simple breathing drill shows promise for asthmatic children
Symptom relief CompletedThis study tested whether adding a special breathing exercise, called expiratory muscle training, to standard chest physiotherapy helps children with asthma. Thirty children aged 8 to 18 were randomly assigned to either standard care or standard care plus the breathing exercise, …
Phase: NA • Sponsor: Atlas University • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
New drug 9MW1911 tested for safety in first human trial
Symptom relief CompletedThis Phase 1 trial tested the safety and tolerability of a new drug called 9MW1911 in 48 healthy adults. The drug is being developed for asthma, COPD, and atopic dermatitis. Participants received either the drug or a placebo by IV infusion, and researchers monitored side effects …
Phase: PHASE1 • Sponsor: Mabwell (Shanghai) Bioscience Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 08:04 UTC
-
New study checks if dupixent makes life better for severe asthma patients
Symptom relief CompletedThis study followed 112 adults with severe asthma who were starting treatment with dupilumab (Dupixent). Researchers measured changes in quality of life using a standard questionnaire at 12, 24, and 52 weeks. The goal was to see if the drug helps people feel better and breathe ea…
Sponsor: Sanofi • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Could a Mitochondria-Targeting pill ease asthma in obesity?
Symptom relief CompletedThis completed Phase 1 trial tested whether MitoQ, a drug that targets cell energy centers, can improve airway reactivity in 47 obese adults with poorly controlled asthma. Participants took MitoQ or a placebo daily for 12 weeks. The study aimed to see if MitoQ could help control …
Phase: PHASE1 • Sponsor: University of Vermont • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
One shot vs three days: which steroid wins for Kids' asthma?
Symptom relief CompletedThis study compared a single IV dose of dexamethasone to three days of oral prednisolone for treating acute asthma attacks in children aged 2 to 12. A total of 224 children participated, and the severity of their asthma was measured using a standard score. The goal was to see if …
Phase: NA • Sponsor: Muhammad Aamir Latif • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
New asthma drug IBI3002 tested in first human trial
Symptom relief CompletedThis early-stage trial tested a single dose of the experimental drug IBI3002 in 52 healthy volunteers and people with mild to moderate asthma. The main goal was to check safety and how the body processes the drug. Researchers monitored side effects and drug levels in the blood ov…
Phase: PHASE1 • Sponsor: Innovent Biologics (Suzhou) Co. Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
Can a 9-Minute chat improve asthma in kids?
Symptom relief CompletedThis study tested a short, scripted conversation between doctors, children with asthma, and their caregivers to improve asthma control. The program, called BREATHE-Peds, was designed for urban youth aged 10-14 who receive care at community health centers. The goal was to see if i…
Phase: NA • Sponsor: Columbia University • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
Can a health coach help lung patients get better care?
Symptom relief CompletedThis study tested whether a health coach can help low-income patients with COPD or asthma get better access to lung specialists and follow their advice. 328 patients from public clinics were randomly assigned to either usual care or a health coach who prepared them for specialist…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
New asthma inhaler tested in teens: early safety check
Symptom relief CompletedThis early-stage study tested a single inhaled dose of a new drug called AZD8630 in 10 teenagers with asthma. The main goal was to see how the drug moves through the body and to check for any safety issues. Participants used a dry powder inhaler and were monitored for side effect…
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
New asthma inhaler shows promise in early safety trial
Symptom relief CompletedThis early-stage study tested an experimental inhaler called AZD8630 in 24 adults with asthma who already use medium-to-high dose steroid inhalers and long-acting bronchodilators. Participants took the drug once daily for 2 weeks to check its safety, how the body processes it, an…
Phase: PHASE1 • Sponsor: AstraZeneca • Aim: Symptom relief
Last updated Jun 27, 2026 07:53 UTC
-
New vibrating vest aims to make lung clearance easier for chronic lung patients
Symptom relief CompletedThis study tested a wearable vest called ELECTROVEST that vibrates and gently stimulates muscles to help clear mucus from the lungs. It included 21 adults with COPD, cystic fibrosis, bronchiectasis, or asthma. The vest was compared to a standard chest-vibration device to see if i…
Phase: NA • Sponsor: Hospitales Universitarios Virgen del Rocío • Aim: Symptom relief
Last updated Jun 26, 2026 18:17 UTC
-
Could a new drug finally silence chronic cough?
Symptom relief CompletedThis study tested whether mepolizumab, a drug already used for asthma, can reduce coughing in people with chronic cough and eosinophilic airway disease. 46 adults received either the drug or a placebo over 12 weeks. The main goal was to see if cough frequency decreased, measured …
Phase: PHASE4 • Sponsor: McMaster University • Aim: Symptom relief
Last updated Jun 26, 2026 17:49 UTC
-
Could thyme oil help you breathe easier? new study tests it for asthma
Symptom relief CompletedThis study tested whether inhaling thyme oil can help people with asthma control their symptoms and improve lung function. 156 adults admitted to a hospital in Turkey used either a thyme oil inhaler, an empty inhaler, or no inhaler for four days. Researchers measured asthma contr…
Phase: NA • Sponsor: Inonu University • Aim: Symptom relief
Last updated Jun 26, 2026 17:45 UTC
-
New asthma drug passes first safety hurdle in small trial
Symptom relief CompletedThis early-stage trial tested the safety and tolerability of a new drug called SAR443765 in 36 people, including healthy volunteers and those with mild-to-moderate asthma. Participants received either the drug or a placebo, and researchers monitored for side effects and how the d…
Phase: PHASE1 • Sponsor: Sanofi • Aim: Symptom relief
Last updated Jun 26, 2026 16:26 UTC
-
New asthma inhaler shows promise in early trial
Symptom relief CompletedThis study tested a single dose of a new albuterol inhaler called PT007 in 118 adults with asthma. Researchers compared how well it opened airways and its safety against a placebo inhaler and the standard Ventolin inhaler. The goal is to see if PT007 works as a quick-relief treat…
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Symptom relief
Last updated Jun 26, 2026 13:14 UTC
-
Scientists track severe asthma over years to unlock new treatments
Knowledge-focused CompletedThis study followed 171 adults with severe asthma, milder asthma, or no asthma over several years. Researchers collected health data, lung tests, and samples to understand how severe asthma progresses and differs from other forms. The goal is to find new ways to treat people whos…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Scientists investigate link between asthma and severe RSV infections
Knowledge-focused CompletedThis study examined whether a chemical called TGF-Beta, which is more common in the lungs of people with asthma, makes them more vulnerable to respiratory syncytial virus (RSV). Researchers collected lung cells from 113 healthy adults and mild asthmatics using a bronchoscopy. The…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Jul 04, 2026 00:00 UTC
-
Nasal clues could unlock new asthma attack treatment
Knowledge-focused CompletedThis pilot study tracks changes in a specific inflammatory marker (IL-1β) in the nasal passages of adolescents during an asthma attack. Researchers collect nasal fluid samples daily for five days during an attack and compare them to baseline samples taken when the participant is …
Sponsor: University of North Carolina, Chapel Hill • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Scientists probe why tezepelumab doesn't stop all asthma attacks
Knowledge-focused CompletedThis observational study looks at why some people with severe asthma continue to have flare-ups even while taking tezepelumab, an approved treatment. Researchers will track 150 patients over a year, measuring changes in inflammatory cells and markers in blood and airways during a…
Sponsor: Guy's and St Thomas' NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jul 01, 2026 00:00 UTC
-
Farming exposures under the microscope: massive health study follows 90,000 participants
Knowledge-focused CompletedThis study follows nearly 90,000 farmers and their spouses to track long-term health effects of pesticides, crops, and animals. Participants report new medical conditions, which researchers then confirm through medical records and genetic samples. The goal is to better understand…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
New study reveals hidden dangers of severe asthma in kids
Knowledge-focused CompletedThis study tracked 60 children aged 5 to 15 who survived a near fatal asthma attack in the UK and Ireland. Researchers collected data on risk factors, medical care, and social and environmental influences. The goal is to create better care guidelines and reduce future risks.
Sponsor: University of Edinburgh • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:03 UTC
-
Robot tutor for kids with asthma: a new way to learn?
Knowledge-focused CompletedThis study looks at whether a friendly robot can help children with asthma learn how to manage their condition. About 120 kids and their parents will test the robot's lessons and activities. The goal is to see if the robot is easy to use and helpful in a clinic setting.
Phase: NA • Sponsor: University of Miami • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:01 UTC
-
ER wait after admission costs millions, study finds
Knowledge-focused CompletedThis study looked at over 30,000 adults admitted to hospitals in Maryland to understand why some patients wait in the emergency room even after being admitted (called boarding). Researchers wanted to find out what patient traits lead to longer waits, how boarding increases health…
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Gene study may unlock secrets of allergies and asthma
Knowledge-focused CompletedThis study looked at how small differences in the COX-2 gene affect the balance of immune cells that play a role in allergies and asthma. Researchers analyzed blood and urine samples from 117 adults who were part of a larger genetic registry. No treatments were given; the goal wa…
Sponsor: National Institute of Environmental Health Sciences (NIEHS) • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
CT scan could predict asthma drug success, saving months of trial and error
Knowledge-focused CompletedThis study tested whether a CT scan of the lungs could predict which patients with severe eosinophilic asthma would respond well to the drug benralizumab. 59 adults received benralizumab for 48 weeks and had CT scans at the start, middle, and end of treatment. The goal was to see…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Asthma drug delivery tested in healthy volunteers
Knowledge-focused CompletedThis study tested two different injection devices (a safety syringe and an autoinjector) to see how the body absorbs depemokimab, a potential asthma treatment. 140 healthy adults received a single dose. The goal was to compare the drug levels in the blood, not to treat asthma.
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Could AI help pharmacists give better advice?
Knowledge-focused CompletedThis study tests whether pharmacists using a generative AI tool (ChatGPT) can provide more accurate and complete medication counseling compared to standard practice. The trial involves 136 adults with chronic conditions like diabetes, high blood pressure, or asthma who are pickin…
Phase: NA • Sponsor: University of Petra • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
New study digs into asthma genes in african ancestry groups
Knowledge-focused CompletedThis completed study looked at 83 adults of African, African American, or African Caribbean descent to find genetic and environmental factors linked to asthma. Participants provided blood, skin, and breathing test data. The goal was to build a resource for future research, not to…
Sponsor: National Human Genome Research Institute (NHGRI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:07 UTC
-
Asthma nebulizer showdown: which mode delivers best?
Knowledge-focused CompletedThis completed study tested different ways to use a nebulizer for asthma medication. 36 people with mild to moderate asthma received the drug salbutamol through various nebulization modes. The goal was to see which mode delivers more medication to the lungs and reduces waste. Res…
Phase: PHASE4 • Sponsor: Beni-Suef University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Scientists collect lung samples to unlock asthma mysteries
Knowledge-focused CompletedThis study collected fluid and cells from the lungs of 574 people with asthma and healthy volunteers using a thin tube called a bronchoscope. The goal was to learn more about airway inflammation and what causes it. The findings may help identify new targets for future asthma trea…
Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Is it asthma or something else? sleep apnea study rethinks wheezing
Knowledge-focused CompletedThis study looked at the medical records of one person from a sleep clinic to see if their breathing problems were due to a condition called dysanapsis (where airways are smaller than normal) rather than true asthma. The goal was to better understand why some people with sleep ap…
Sponsor: Norfolk and Norwich University Hospitals NHS Foundation Trust • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
Asthma drug DUPIXENT under the microscope in Real-World registry
Knowledge-focused CompletedThis completed registry followed 718 asthma patients who were starting treatment with DUPIXENT as part of their normal care. Researchers collected information on patient backgrounds, how the drug was used, its long-term effectiveness, and safety in everyday settings. The goal was…
Sponsor: Regeneron Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Massive asthma screening in china tests community health approach
Knowledge-focused CompletedThis study involved over 9,000 adults in China who might have asthma. Researchers tested a program where doctors were rewarded for helping the whole community's health. People in the program got health checks, lung tests, and advice on smoking, mental health, weight, and blood pr…
Phase: NA • Sponsor: Peking Union Medical College • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC
-
Massive study reveals hidden dangers of common steroid treatments
Knowledge-focused CompletedThis completed study looked at over 107,000 patients in Germany to understand the long-term side effects of systemic steroids (corticosteroids) used for conditions like asthma, COPD, and arthritis. Researchers compared patients who took steroids with those who did not, tracking r…
Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Heat wave warning: study reveals how chronic illness patients suffer in high temperatures
Knowledge-focused CompletedThis completed study looked at how rising temperatures affect people with chronic conditions like heart disease, diabetes, and depression. Researchers in Germany and Italy surveyed 176 patients to see what symptoms they experienced during heat and what protective steps they took.…
Sponsor: Universitätsklinikum Hamburg-Eppendorf • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
New home device may predict asthma attacks before they happen
Knowledge-focused CompletedThis study tested a new way to monitor breathing at home in 120 adults with severe asthma. The goal was to see if a special analysis of resting breath patterns could predict when an asthma attack might occur. The approach is observational and aims to improve early warning, not to…
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
New study aims to predict breathing muscle strength without fancy gear
Knowledge-focused CompletedThis completed observational study included 123 adults with COPD or asthma. Researchers measured breathing muscle strength using a special device and then tried to predict those results from simpler tests like spirometry and body composition. The goal was to see if doctors could …
Sponsor: Hitit University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Pandemic lockdowns: a surprising effect on Kids' asthma?
Knowledge-focused CompletedThis study looked at how the COVID-19 pandemic and related public health measures changed asthma control in children aged 3 to 16. Researchers compared asthma control and flare-ups in 577 children during the pandemic to data from before the pandemic. The goal was to see if lockdo…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC
-
Blood cell study may personalize asthma and sinusitis treatment
Knowledge-focused CompletedThis study looked at different types of immune cells (eosinophils) in the blood of people with asthma, chronic sinusitis with nasal polyps, or both, compared to healthy volunteers. The goal was to find patterns that could help doctors choose the best targeted therapy for each pat…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
New breathing test for turkish asthma patients under review
Knowledge-focused CompletedThis study checked whether a Turkish version of the Brompton Breathing Pattern Assessment Tool (BPAT) works well for people with asthma. Researchers tested 101 Turkish-speaking adults with severe asthma to see if the tool gives consistent results and matches other breathing tests…
Sponsor: Istanbul Saglik Bilimleri University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC
-
Scientists probe the hidden types of severe childhood asthma
Knowledge-focused CompletedThis completed study looked at 54 children with severe asthma to better understand the different biological features (endotypes) of the disease. Researchers collected blood, saliva, and nasal samples, along with lung samples from bronchoscopies, to analyze immune cells, metabolis…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC
-
New app aims to help chronic patients breathe easier while walking
Knowledge-focused CompletedThis study tested how easy and acceptable the P-STEP mobile app is for people with chronic conditions like asthma, COPD, heart disease, or diabetes. 178 adults in Leicester, UK used the app for 12 weeks to track their walking and get air quality updates. The main goal was to meas…
Sponsor: University of Leicester • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Asthma drug HBM9378 passes first safety check in healthy people
Knowledge-focused CompletedThis early-stage study tested a single injection of HBM9378 in 50 healthy Chinese adults to see if it is safe and how the body processes it. The goal was not to treat asthma but to gather safety and drug-level data. Participants were healthy, not asthma patients, so no direct ben…
Phase: PHASE1 • Sponsor: Harbour BioMed (Guangzhou) Co. Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
Scientists dive deep into asthma attacks to find new clues
Knowledge-focused CompletedThis study looked at blood and airway samples from 23 adults during an acute asthma attack and again after recovery. The goal was to understand what happens in the body during an attack. This is a pilot study, meaning it is small and meant to generate ideas for future research, n…
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:28 UTC
-
New app aims to help teens with asthma catch better zzzs
Knowledge-focused CompletedThis study tested a mobile app designed to help teenagers with asthma learn about healthy sleep habits. 120 teens aged 14-17 with asthma used the app or were in a comparison group. Researchers measured changes in sleep knowledge, confidence, and daytime sleepiness to see if the a…
Phase: NA • Sponsor: KDH Research & Communication • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New asthma drug may change how patients react to aspirin
Knowledge-focused CompletedThis study looked at how dupilumab, a drug for asthma and nasal polyps, affects reactions to aspirin in people with AERD (a severe form of asthma with sinus issues). 16 adults who were already taking dupilumab for at least 12 weeks took part. Researchers measured breathing, nasal…
Phase: PHASE2 • Sponsor: Scripps Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
Mold linked to worse asthma in kids, study finds
Knowledge-focused CompletedThis study looked at 451 children with asthma in northern France to see if mold in their homes made their asthma harder to control. Doctors checked asthma control using standard guidelines and questionnaires. The goal was to better understand how the environment affects children'…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Could depression change how Kids' asthma responds to treatment?
Knowledge-focused CompletedThis study looked at 39 children with asthma to see if those with depression have a different type of airway response. Researchers tested whether an anticholinergic inhaler (ipratropium) works better in depressed versus non-depressed children. The goal was to better understand th…
Phase: EARLY_PHASE1 • Sponsor: State University of New York at Buffalo • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:23 UTC
-
Hospital pathways may help kids with asthma, pneumonia, and bronchiolitis get better care
Knowledge-focused CompletedThis study looked at whether a set of care guidelines (called a pathway) could help doctors and nurses in community hospitals use the best treatments for children hospitalized with asthma, pneumonia, or bronchiolitis. Over 11,000 children took part across many hospitals. The goal…
Phase: NA • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
New study tracks COVID vaccine durability in chronic illness patients
Knowledge-focused CompletedThis completed study followed 360 adults and children with chronic respiratory and other medical conditions to see how their immune systems responded to COVID-19 vaccines over 18 months. Researchers measured antibody, T cell, and B cell levels before vaccination and every 3 month…
Sponsor: National Jewish Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
New inhaler propellant put to the test in healthy volunteers
Knowledge-focused CompletedThis completed phase 1 study in 24 healthy adults compared a new inhaler propellant (HFA-152a) to a standard one (HFA-134a) to see if it affects how the lungs clear mucus. Participants inhaled each propellant for several days, and lung clearance was measured using a radioactive t…
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
SNIFF TEST: nasal swab may reveal lung disease severity
Knowledge-focused CompletedThis completed study looked at whether substances in nasal fluid can help doctors objectively measure the severity of respiratory conditions like asthma, COPD, hayfever, and sinusitis. Researchers collected samples from 111 adults (including healthy volunteers) using a small nasa…
Sponsor: Diag-Nose Medical Pty Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Can your Child's environment predict asthma attacks?
Knowledge-focused CompletedThis completed observational study followed 2,660 children aged 5 to 16 with and without asthma to understand how environment and biology affect asthma control. Researchers collected saliva, nasal, and urine samples to find predictors of asthma flare-ups and medication adherence.…
Sponsor: Stefania La Grutta, MD • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Asthma lessons boost Kids' quality of life, study finds
Knowledge-focused CompletedThis study looked at whether teaching children with asthma about their condition helps them understand it better, control symptoms, and feel better day-to-day. 70 children aged 7-11 took part. Researchers measured asthma knowledge, control, and quality of life before and after th…
Phase: NA • Sponsor: Dokuz Eylul University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
New antibody tested in healthy volunteers – no cure yet
Knowledge-focused CompletedThis early-stage study tested a single dose of the experimental antibody SM17 in 30 healthy Chinese adults to see if it is safe and how the body processes it. The study did not aim to treat any disease. Results will help plan future trials for conditions like eczema, asthma, and …
Phase: PHASE1 • Sponsor: SinoMab BioScience Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC
-
Scientists compare nose and lung cells to unlock allergy secrets
Knowledge-focused CompletedThis study looked at gene activity in cells from the nose and lungs of 44 healthy and allergic adults. The goal was to understand how allergies change these cells and why the nose and lungs react differently. Researchers hope this knowledge will lead to better treatments for alle…
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Obesity and asthma: scientists probe hidden airway damage
Knowledge-focused CompletedThis study looked at why obese people with asthma often have more severe symptoms and don't respond well to standard treatments. Researchers used special MRI scans and genetic analysis to examine airway changes in 49 obese adults with asthma. The goal was to better understand the…
Phase: PHASE2 • Sponsor: Bastiaan Driehuys • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
AI may predict patient decline at home before it happens
Knowledge-focused CompletedThis study tested a machine learning algorithm to predict if a patient being cared for at home would deteriorate. Researchers used data from over 500 patients to train the algorithm and compared its alerts to traditional vital sign alarms. The goal is to catch problems earlier an…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Asthma Drug's gene secrets revealed in small study
Knowledge-focused CompletedThis study looked at how the asthma drug mepolizumab affects gene activity in adults with severe eosinophilic asthma. Researchers took blood samples from 20 participants before and after 12 weeks of treatment to see which genes changed. The goal was to understand how the drug wor…
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
AI predicts hospital comebacks: a data dive
Knowledge-focused CompletedThis study looked at data from 372 patients to see if a computer program could predict who would need to be readmitted to the hospital within 30 days. Researchers used information like age and health history to train the computer model. The goal was to find patterns that could he…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
New study monitors kids hospitalized for severe breathing issues
Knowledge-focused CompletedThis study observed over 1,800 children hospitalized for serious breathing problems like bronchiolitis, pneumonia, or asthma. It aimed to track how many children were hospitalized for bronchiolitis after a new immunization became available. The study did not test any new treatmen…
Sponsor: Association Clinique Thérapeutique Infantile du val de Marne • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Do parents know how air pollution affects their allergic kids? new study finds out.
Knowledge-focused CompletedThis study surveyed 500 parents of children with asthma or allergic rhinitis to see how much they know about air quality and pollution. The goal was to understand their awareness, knowledge, and protective behaviors. The results will help design better education and prevention pr…
Sponsor: Prof. Dr. Cemil Tascıoglu Education and Research Hospital Organization • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:02 UTC
-
Blood type clues to asthma Flare-Ups?
Knowledge-focused CompletedThis study looked at whether a person's blood group antigens are linked to asthma attacks. Researchers followed 126 people with asthma to see if certain blood types had more flare-ups requiring steroids. The goal was to understand, not treat, the disease.
Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
Home visits may ease asthma and allergy symptoms in kids
Knowledge-focused CompletedThis study looked at whether a home visit by an environmental counselor can improve the quality of life for children with asthma or allergic rhinitis. Researchers checked the children's health at the start and again six months after the visit using standard questionnaires. The st…
Sponsor: University Hospital, Angers • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC
-
New asthma drug candidate passes early safety check in healthy volunteers
Knowledge-focused CompletedThis study tested an experimental drug called XKH001 in 24 healthy adults to see if it is safe and how the body processes it. Participants received either the drug or a placebo by injection. The goal was to check for side effects and measure drug levels in the blood, not to treat…
Phase: PHASE1, PHASE2 • Sponsor: Beijing Kanova Biopharmaceutical Co., LTD • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
Dupilumab in pregnancy: no major safety signals found
Knowledge-focused CompletedThis study looked at whether the drug dupilumab, used for eczema or asthma, is safe during pregnancy. Researchers compared 581 pregnant women who took dupilumab with those who did not. They tracked birth defects, miscarriages, and infant health up to one year old to see if the dr…
Sponsor: Regeneron Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:11 UTC
-
New inhaled drug passes first safety check in healthy volunteers
Knowledge-focused CompletedThis early-stage study tested a single dose of an inhaled drug called DBM-1152A in 44 healthy Chinese adults. The main goal was to see if the drug is safe and how the body processes it. No treatment was given for any disease; the study simply gathered safety information to guide …
Phase: PHASE1 • Sponsor: Joincare Pharmaceutical Group Industry Co., Ltd • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC
-
Pandemic stress takes toll on asthma Patients' daily lives
Knowledge-focused CompletedThis study looked at how the COVID-19 pandemic affected the quality of life of 200 adults with asthma. Researchers wanted to understand what caused extra stress—like staying home, using more disinfectants, or worrying that asthma symptoms might be COVID-19. The goal was to find o…
Sponsor: Cairo University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
New turkish scale helps measure breathing trouble in silent patients
Knowledge-focused CompletedThis study tested a Turkish version of the Respiratory Distress Observation Scale (RDOS) in 100 adult palliative care patients who cannot describe their breathing trouble. The scale uses eight physical signs like heart rate and restlessness to rate distress. The goal was to see i…
Sponsor: Istinye University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Can a workout change your asthma genes?
Knowledge-focused CompletedThis study looked at how different breathing exercises affect genes and symptoms in 84 adults with severe asthma. Participants did either standard respiratory rehab or the same program plus extra muscle-strengthening breathing exercises. Researchers measured changes in a specific…
Phase: NA • Sponsor: Saglik Bilimleri Universitesi • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Stepping up asthma care: new test may replace treadmill
Knowledge-focused CompletedThis study tested whether a 6-minute stepper test is a valid and reliable way to measure exercise capacity in adults with asthma. 41 participants with well-controlled asthma performed the stepper test and a standard treadmill test. The goal was to see if the simpler stepper test …
Sponsor: Gazi University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:01 UTC
-
Can a nasal air device calm Asthma's hidden nerve stress?
Knowledge-focused CompletedThis completed study looked at how nasal high-flow therapy (NHFT) affects breathing and the nervous system in 30 adults with asthma. Researchers measured nerve activity and heart rate to see if NHFT could reduce overactive stress signals. The goal was to gather knowledge, not to …
Sponsor: RWTH Aachen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Asthma and obesity study probes Dupilumab's cellular effects
Knowledge-focused CompletedThis study looked at how the drug dupilumab changes gene and protein activity in airway cells from adults with asthma and obesity. Researchers compared allergic and non-allergic participants to understand different treatment responses. The goal was to gather knowledge, not to tes…
Sponsor: Duke University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Real-World data on tezepelumab for severe asthma: what happens outside trials?
Knowledge-focused CompletedThis study looked back at medical records of 352 adults with severe asthma who started taking tezepelumab in UK hospitals between January 2023 and March 2024. Researchers wanted to see how often patients had asthma attacks and whether they needed oral steroids during the year aft…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Paper vs email: which gets doctors to switch to greener asthma inhalers?
Knowledge-focused CompletedThis study looked at whether sending paper letters along with emails helps doctors change how they prescribe asthma inhalers. The goal was to increase use of inhalers that are better for the environment and improve patient care. 273 primary care practices in West Yorkshire took p…
Phase: NA • Sponsor: University of Leeds • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Asthma study probes deep lung inflammation
Knowledge-focused CompletedThis study looked at inflammation in the small airways of the lungs in people with asthma. Researchers tested whether a steroid with small particles could reach these deep areas better than a steroid with large particles. 57 adults with mild to moderate asthma took part. The goal…
Phase: PHASE1 • Sponsor: University of California, Los Angeles • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:13 UTC
-
Blood protein fingerprint may reveal lung disease secrets
Knowledge-focused CompletedThis study looked at whether a family of proteins called GPCRs, found on the surface of cells, can be used as biomarkers to diagnose or track chronic lung diseases like asthma and COPD. Researchers analyzed blood samples from 205 people (healthy volunteers and patients) to see if…
Phase: NA • Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Farm life could shield children from bad colds and asthma
Knowledge-focused CompletedThis study looked at whether children who grow up on farms, with more exposure to microbes, have fewer severe colds and breathing problems. Researchers tracked 290 children aged 4 to 12, including farm kids and city kids with and without asthma. The goal was to understand how ear…
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Vitamin d in pregnancy may shape Child's lung health
Knowledge-focused CompletedThis study looks at whether low vitamin D levels in early pregnancy are linked to breathing problems in children ages 5 to 6. Researchers measured airway resistance in 142 children whose mothers had vitamin D levels checked during the first trimester. The goal is to understand if…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
Real-World data on tezepelumab for severe asthma released
Knowledge-focused CompletedThis study looked back at medical records of 420 people with severe asthma in Spain who were given tezepelumab after it was approved. The goal was to see how well the drug works in real life, not just in controlled trials. Researchers tracked things like asthma attacks, symptoms,…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
New asthma inhaler ingredient tested in healthy volunteers
Knowledge-focused CompletedThis study tested a new propellant (HFA-152a) in salbutamol inhalers to see if it works like the current propellant (HFA-134a). Sixty healthy adults aged 18-55 received single doses of salbutamol via both inhalers. The goal was to measure how much drug gets into the blood and how…
Phase: PHASE1 • Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Doctor training program aims to boost asthma control
Knowledge-focused CompletedThis study tested whether a program that educates doctors on the latest asthma guidelines can improve how they treat patients. About 1500 people with asthma in China took part. The program included training sessions and reminders to help doctors follow best practices. The main go…
Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Chewing gum may skew asthma test results, study warns
Knowledge-focused CompletedThis study looked at whether chewing gum changes a key asthma breath test called FeNO. Researchers had 30 adults with asthma chew a special sugar-free gum for 15 minutes and then measured their FeNO levels. The goal was to see if gum could cause wrong readings that might lead to …
Phase: NA • Sponsor: RWTH Aachen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Asthma literacy scale for children developed
Knowledge-focused CompletedResearchers created a questionnaire to measure how well children aged 8-12 with asthma understand their condition. The scale, tested in 196 children, has 19 questions and is reliable. It could help tailor education to improve asthma management.
Sponsor: University of Yalova • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Can biotherapy keep severe asthma patients productive at work?
Knowledge-focused CompletedThis study looked at 174 adults with severe asthma who were starting biotherapy. Researchers wanted to see if their ability to work (despite health issues) improved after 6 months of treatment. The goal was to understand which factors, like asthma control or other health problems…
Sponsor: University Hospital, Lille • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Bakers' asthma linked to grass pollen? new study investigates
Knowledge-focused CompletedThis study examined 403 adults to see if grass pollen allergies are more common in workers exposed to flour, like bakers and pastry chefs, compared to other professions. Researchers analyzed past medical records to understand what factors influence asthma symptoms in these worker…
Sponsor: Centre Hospitalier Intercommunal Creteil • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
New breathing monitor could help doctors spot lung trouble faster
Knowledge-focused CompletedThis study tested whether a device called MYOTRACE, which measures how hard a person's breathing muscles are working, can help doctors assess patients with respiratory diseases. 56 adults with conditions like COPD or asthma were included. The goal was to see if the device's readi…
Sponsor: Philips Clinical & Medical Affairs Global • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Asthma Drug's hidden effects revealed in small study
Knowledge-focused CompletedThis study looked at how mepolizumab, a biologic drug, changes inflammation in people with severe eosinophilic asthma. Researchers measured immune and metabolic markers in the nose, lungs, and blood of 15 adults. The goal was to better understand the drug's full impact beyond jus…
Sponsor: Istituti Clinici Scientifici Maugeri SpA • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC
-
Heat waves and dirty air worsen lung disease, study finds
Knowledge-focused CompletedThis study followed 96 adults with asthma or COPD in Mersin, Türkiye, to see how extreme heat waves and air pollution impact their lung health. Researchers measured lung function, airway inflammation, symptoms, and quality of life during normal weather and again during heat waves…
Sponsor: Mersin University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Smart inhalers track Kids' asthma attacks to build better action plans
Knowledge-focused CompletedThis study observed 120 children with asthma, aged 3 to 11, using smart inhalers to track how and when they used emergency medication at home. Parents also answered questions via a mobile app about symptoms and treatment effectiveness. The goal was to gather real-world data to cr…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Breath by breath: new study maps lung drug delivery in asthma and COPD
Knowledge-focused CompletedThis study measured breathing patterns in 163 adults with asthma or COPD to help computers predict how much of an inhaled drug actually reaches the lungs. Researchers used these real-world breathing measurements to improve simulations of aerosol drug deposition. The goal is to ma…
Sponsor: Medisol Development Kft. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
Scientists probe immune Molecule's role in stuffy nose disease
Knowledge-focused CompletedThis study looked at how a molecule called IL-5 affects different cells in the sinuses of people with nasal polyps and a related condition called aspirin-exacerbated respiratory disease. Researchers analyzed tissue samples from 30 participants to understand how IL-5 contributes t…
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:59 UTC
-
Hidden breathing blockage found in severe asthma patients
Knowledge-focused CompletedThis study looked at how often people with severe asthma also have inducible laryngeal obstruction (ILO), a condition where the voice box closes during exercise, making breathing harder. Researchers tested 116 participants using a special scope while they walked on a treadmill an…
Sponsor: Haukeland University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Cough-Counting app tested in 616 patients
Knowledge-focused CompletedThis study tested a smartphone app called Hyfe Cough Tracker to see if it can accurately count coughs in people with lung conditions like COPD, asthma, or COVID-19. Researchers compared the app's cough counts to patients' own reports and expert listening. The goal was to improve …
Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Grip strength may predict which asthma inhaler works best for you
Knowledge-focused CompletedThis study looked at 80 newly diagnosed asthma patients to see if their muscle strength affects how well they respond to two types of inhalers: a metered dose inhaler (MDI) and a dry powder inhaler (DPI). All patients had at least a high school education and used the inhalers per…
Phase: NA • Sponsor: Bugra Kerget • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Body scans may reveal who benefits from asthma biologics
Knowledge-focused CompletedThis study looked at CT scans from 233 severe asthma patients to see if body composition (like chest muscle size and quality) could predict how well they respond to biologic therapies. Researchers used advanced imaging analysis to find biomarkers linked to fewer asthma attacks. T…
Sponsor: University of Michigan • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
Common asthma drugs linked to bone loss in large study
Knowledge-focused CompletedThis study looked at nearly 20,000 adults with asthma to see if long-term use of inhaled or oral steroids increases the risk of osteoporosis (weak bones) and other metabolic diseases like diabetes and high blood pressure. Researchers compared people who took higher total doses of…
Sponsor: Ajou University School of Medicine • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:58 UTC
-
E-Cigarettes tested as a safer alternative for asthmatic smokers
Knowledge-focused CompletedThis study gave free e-cigarettes to 17 adult smokers with asthma for 8 weeks to see if they would smoke fewer regular cigarettes and have better lung function. Researchers measured changes in smoking habits, dependence, and asthma symptoms. The goal was to gather early informati…
Phase: NA • Sponsor: Brown University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Asthma inhaler tracker reveals teen medication habits
Knowledge-focused CompletedThis study followed 80 teens with asthma to see how well they used their daily controller and rescue inhalers. Participants used an electronic device that reminded them to take their medication and shared their usage patterns with their doctor and family. The goal was to group te…
Phase: NA • Sponsor: University of Colorado, Denver • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Portuguese study reveals how benralizumab works in real life for severe asthma
Knowledge-focused CompletedThis completed study looked back at medical records of 74 adults in Portugal with severe eosinophilic asthma who were treated with benralizumab. Researchers wanted to describe patient characteristics, treatment patterns, and outcomes in real-world settings. The study did not test…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Grass allergy test study seeks better standardization
Knowledge-focused CompletedThis study aimed to find the right strength of two grass allergen extracts (timothy and orchard grass) to cause a skin reaction similar to histamine. Thirty-one adults with grass pollen allergies received skin prick tests with different concentrations. The goal was to improve all…
Phase: NA • Sponsor: Inmunotek S.L. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Blood drug levels may explain why some asthma patients Don't respond to mepolizumab
Knowledge-focused CompletedThis study measured the amount of mepolizumab in the blood of 50 adults with severe asthma who were already taking the drug. Researchers compared drug levels between those who responded well to treatment and those who did not. The goal was to see if differences in how the body pr…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC
-
Scientists grow mini lung tissue from blood to study severe asthma
Knowledge-focused CompletedThis completed study took blood samples from 4 people with severe asthma or a related condition called ABPA. Researchers used the blood cells to create stem cells and then grew them into tiny models of bronchial tissue. The goal was to see if this lab-grown tissue could mimic rea…
Phase: NA • Sponsor: University Hospital, Montpellier • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC
-
Egyptian asthma study reveals steroid reliance
Knowledge-focused CompletedThis study measured how often people with severe asthma in Egypt use oral corticosteroids (OCS), a common but strong medication. Researchers looked at 201 patients across multiple clinics to understand treatment patterns and asthma types. The goal was to gather information, not t…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Severe asthma under the microscope: new study watches Real-World outcomes
Knowledge-focused CompletedThis completed study followed 18 adults with severe asthma in the United States for at least 3 years. Researchers collected data on treatments, symptoms, hospital visits, and quality of life from medical records and monthly patient surveys. The goal was to understand how severe a…
Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC
-
Breath test may predict who responds to common asthma drug for chronic cough
Knowledge-focused CompletedThis study looked at 1000 adults with chronic dry or nighttime cough to find a cutoff value for a breath test called FeNO that can predict whether they will respond to the asthma medication budesonide-formoterol. Participants took the drug twice daily for 8 weeks, and their cough…
Phase: PHASE4 • Sponsor: AstraZeneca • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:40 UTC
-
Asthma care revolution? families and doctors share what they really want
Knowledge-focused CompletedThis completed study involved 307 children with asthma, their parents, and doctors. Participants ranked goals for asthma treatment, like preventing attacks or making medication easier to take. The aim was to gather preferences to guide future algorithm-based management tools.
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 16:34 UTC
-
Asthma treatment under the microscope: how trimbow works in daily life
Knowledge-focused CompletedThis completed study followed 147 adults with moderate to severe asthma who were prescribed Trimbow, a triple-therapy inhaler, as part of their routine care. Researchers collected data on patient characteristics, treatment patterns, asthma control, quality of life, and lung funct…
Sponsor: Chiesi UK • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:42 UTC
-
Premature Babies' lungs tracked into teen years
Knowledge-focused CompletedThis study follows 355 teenagers who were born very prematurely (26–32 weeks) in 1997 in France. Researchers measure their lung function and breathing symptoms to see how preterm birth affects respiratory health later in life. It is an observational study, meaning no treatment is…
Phase: NA • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:00 UTC